» Articles » PMID: 30311405

The Dynamic RNA Modification 5-methylcytosine and Its Emerging Role As an Epitranscriptomic Mark

Overview
Publisher Wiley
Date 2018 Oct 13
PMID 30311405
Citations 170
Authors
Affiliations
Soon will be listed here.
Abstract

It is a well-known fact that RNA is the target of a plethora of modifications which currently amount to over a hundred. The vast majority of these modifications was observed in the two most abundant classes of RNA, rRNA and tRNA. With the recent advance in mapping technologies, modifications have been discovered also in mRNA and in less abundant non-coding RNA species. These developments have sparked renewed interest in elucidating the nature and functions of those "epitransciptomic" modifications in RNA. N6-methyladenosine (m A) is the best understood and most frequent mark of mRNA with demonstrated functions ranging from pre-mRNA processing, translation, miRNA biogenesis to mRNA decay. By contrast, much less research has been conducted on 5-methylcytosine (m5C), which was detected in tRNAs and rRNAs and more recently in poly(A)RNAs. In this review, we discuss recent developments in the discovery of m5C RNA methylomes, the functions of m5C as well as the proteins installing, translating and manipulating this modification. Although our knowledge about m5C in RNA transcripts is just beginning to consolidate, it has become clear that cytosine methylation represents a powerful mechanistic strategy to regulate cellular processes on an epitranscriptomic level. This article is categorized under: RNA Processing > RNA Editing and Modification RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications RNA Processing > tRNA Processing RNA Turnover and Surveillance > Regulation of RNA Stability.

Citing Articles

NSUN2/ALYREF axis-driven mC methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer.

Yang Y, Cao L, Xu X, Li D, Deng Y, Li L Cancer Immunol Immunother. 2025; 74(4):132.

PMID: 40029463 PMC: 11876480. DOI: 10.1007/s00262-025-03986-5.


Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer.

Ding Y, Li X, Wang W, Cai L Sci Rep. 2025; 15(1):4405.

PMID: 39910191 PMC: 11799374. DOI: 10.1038/s41598-025-88657-2.


m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon.

Sun Y, Liu Y, Jiang L, Zhong C Front Immunol. 2025; 15:1512353.

PMID: 39867908 PMC: 11757137. DOI: 10.3389/fimmu.2024.1512353.


Epigenetics in the modern era of crop improvements.

Xue Y, Cao X, Chen X, Deng X, Deng X, Ding Y Sci China Life Sci. 2025; .

PMID: 39808224 DOI: 10.1007/s11427-024-2784-3.


Polymorphisms in the gene and neuroblastoma risk in Chinese children from Jiangsu province.

Chang J, Zhou C, Jia W, Zhou H, Yang T, Zhang Z J Cancer. 2025; 16(2):622-628.

PMID: 39744478 PMC: 11685692. DOI: 10.7150/jca.103097.


References
1.
PERRY R, Kelley D, Friderici K, Rottman F . The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5' terminus. Cell. 1975; 4(4):387-94. DOI: 10.1016/0092-8674(75)90159-2. View

2.
Okano M, Xie S, Li E . Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 1998; 26(11):2536-40. PMC: 147598. DOI: 10.1093/nar/26.11.2536. View

3.
Goll M, Kirpekar F, Maggert K, Yoder J, Hsieh C, Zhang X . Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science. 2006; 311(5759):395-8. DOI: 10.1126/science.1120976. View

4.
Sabban E, Bhanot O . The effect of bisulfite-induced C to U transitions on aminoacylation of Escherichia coli glycine tRNA. J Biol Chem. 1982; 257(9):4796-805. View

5.
Tuorto F, Liebers R, Musch T, Schaefer M, Hofmann S, Kellner S . RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat Struct Mol Biol. 2012; 19(9):900-5. DOI: 10.1038/nsmb.2357. View